Due to public health concerns related to COVID-19, Larger Than Life Science is going virtual. Join LaunchBio from anywhere in the world to experience our programming for life science entrepreneurs.
Due to public health concerns related to COVID-19, Larger Than Life Science is going virtual. Join LaunchBio from anywhere in the world to experience our programming for life science entrepreneurs. Our webinars will be live-streaming free on Zoom and made available on our website following the program.
Register today and we’ll send you the link to participate.
Discovery and Development
Bringing a Gene Therapy to Market
Cell and gene therapy-related research and development in the US continue to grow at a fast rate, with the FDA signaling its interest in moving these products to clinical development. While the promise of breakthrough treatments is tantalizing, researchers and pharma companies in the US are still in the early stages of getting these new therapies reviewed, approved and available to patients who need them.
Join our panel for a discussion of the current state of gene therapy commercialization with scientist-entrepreneurs on the front lines of research and discovery.
Michael Hostetler, PhD, Esq., Partner, Wilson Sonsini
Stephanie Scherer, Principal R&D Scientist, Cell Design Studio, MilliporeSigma
H. Joon Chung, Senior Director, Legal I/P, Amicus Therapeutics
Michael Burnham, Director, Vector Development Dept., Tmunity Therapeutics Inc.
Daniel Dornbusch, Chief Executive Officer, Excision Biotherapeutics
(Wednesday) 4:00 pm - 4:45 pm